Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 75 (2), 141-148
- https://doi.org/10.1016/j.radonc.2005.03.028
Abstract
To compare the course of symptoms and health-related quality-of-life (HRQOL) after immediate thoracic radiotherapy (TRT) between symptomatic (S) and non-symptomatic (NS) patients with advanced NSCLC. 407 stage III/IV patients were initially treated with immediate TRT within a randomised phase III trial comparing different fractionation schedules. At inclusion, patients were prospectively stratified according to presence (S) or absence (NS) of tumour-related chest/airway symptoms to facilitate comparison between these groups. The EORTC QLQ-C30 and LC-13 were used for symptom and HRQOL assessments at baseline and at regular intervals up to 1 year (N=395). NS patients had significantly more favourable baseline characteristics when compared to S patients with a median survival of 11.8 versus 6.0 months (P<0.0001), respectively. At baseline, S patients demonstrated HRQOL scores inferior to those of NS patients (P<0.01) for most scales. Until week 14, NS patients developed more symptoms while S patients experienced symptom relief in most scales. After week 14, no significant differences could be observed between the groups. This study indicates that immediate TRT, given to patients with minimal/none chest symptoms, does not prevent development of disease-related symptoms and diminished HRQOL. A wait-and-see policy appears to be acceptable.Keywords
This publication has 19 references indexed in Scilit:
- Lung cancer * 4: Chemotherapy for non-small cell lung cancer: the end of the beginningThorax, 2003
- Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trialBMJ, 2002
- Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinomaCancer, 2001
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal Of Cancer, 1994
- EORTC Quality of Life QuestionnairePublished by American Psychological Association (APA) ,1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Psychosocial Issues in Lung Cancer Patients (Part 1)Chest, 1991
- An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchusClinical Radiology, 1988
- Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- COMPARISON OF TREATMENT POLICIES IN INOPERABLE BRONCHIAL CARCINOMAThe Lancet, 1971